Target Didn't Almost Die in 2022. It Took a Bullet to the Margin On Purpose.

In the summer of 2022, Target reported a quarter that looked like a wound. Operating income fell 87% to $321 million, and gross margin dropped from 30.4% to 21.5% in a single year.¹ Headlines reached for the word every retail crisis attracts: collapse, freefall, near-death. But read the same release one line up and something doesn't fit. Revenue grew 3.5%.¹ People were still walking into Target, still filling carts. The profit didn't vanish because customers left. It vanished because Target shot it.

The story everyone remembers is that Target nearly went under in 2022 and clawed its way back. Almost every beat of that is wrong. Target was never close to going under - and the thing that hammered its profit wasn't a market turning against it. It was a decision the company made on purpose, in public, with a fully loaded balance sheet behind it.

A profit shot, not a profit lost

Here is the mechanism the panic skipped. During the pandemic, Americans bought stuff - furniture, electronics, home goods - and Target ordered for that world. Then demand swung back toward groceries and essentials, and Target was left holding a mountain of discretionary inventory nobody wanted at full price. In June 2022 it announced what it would do about it: cancel purchase orders, pile on promotional and clearance markdowns, and physically clear out the excess.³ That choice is the entire story. Markdowns are subtracted directly from gross margin, so when you clear a glut in one violent push, your profit line takes the hit all at once. The 87% drop wasn't the market punishing Target. It was Target paying, in a lump sum, to undo its own ordering mistake.

The word that matters there is bold, and its opposite is slowly. Target could have bled the excess inventory out over many quarters, hiding the damage in a slow drip of soft margins. Instead it chose to take the pain in a single, ugly, visible quarter. That is a turnaround tactic wearing the costume of a disaster - rip the bandage, restart clean. The market read the headline number and assumed the patient was dying. The patient was performing surgery on itself.

Why this was never a solvency crisis

The clearest tell that 'near-death' is inflation sits in the boring pages of the 10-K. Through both FY2022 and FY2023, Target carried no commercial paper outstanding, and its $3.0 billion revolving credit facility went fully undrawn the entire time.⁶ A company actually fighting for survival raids every line of credit it has. Target touched none of it. Full-year FY2022 operating income, even after the bloodletting, was $3.848 billion - down a brutal 57% from $8.946 billion the year before, but still nearly four billion dollars of profit on $107.6 billion of sales.² You do not nearly die with four billion dollars of operating income and an untouched war chest. The crisis was to the income statement, not the company.

The rebound, and exactly what fixed it

When the comeback came, it confirmed the diagnosis. In FY2023, operating income jumped 48.3% to $5.707 billion, and the operating margin climbed back to 5.3% from 3.5%.⁴ But notice what did not drive it. Revenue actually fell - total revenue dropped 1.6% to $107.4 billion, and comparable sales went negative, down 3.7% for the year.⁴⁵ The profit recovered while the top line shrank. That only happens one way: the cost side healed. The glut was gone, so the punishing markdowns stopped, freight costs eased, and the gross margin that had been crushed reflated. The recovery wasn't a brilliant new business model. It was the absence of a self-inflicted wound.

But isn't a 48% rebound a clean comeback?

The fair objection is that the numbers look triumphant - profit up nearly half, return on invested capital climbing to 16.1% from 12.6%.⁴ Why not just call it a win? Because the recovery rebounded to the wrong line. The FY2023 operating margin of 5.3% is still below the pre-pandemic level near 6% and a long way under the 8.4% peak of FY2021.⁵ Target didn't climb back to where it was; it climbed back to where it was before the boom, minus a little. And the trend after didn't accelerate: in FY2024, net sales slipped 0.8% to $106.6 billion, operating income edged down 2.5%, and comparable sales in the fourth quarter barely scraped positive at +1.5%.⁷ The bleeding stopped. The growth didn't restart. A genuine comeback would show the margin marching back toward its old peak; instead it stalled on a plateau below it.

So the honest read is the unglamorous one. Target's 2022 was not a brush with death - it was an expensive lesson in over-ordering, paid down in a single deliberate quarter by a company that never lost solvency, never lost customers, and never drew a dollar of emergency credit. The rebound that followed proved the wound was self-inflicted, because curing it required nothing more than ceasing to inflict it. The hard part was always going to come next: not recovering the margin it gave away, but growing past the ceiling it has been sitting under ever since. A company can stop bleeding in one quarter. Climbing back to its own best self takes a great deal longer - and Target, for now, is still on the way.